Adrestia Therapeutics
Babraham
About Adrestia Therapeutics
Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $232.6M
- Funding stage: M&A
- Last round: Series A (Dec 2020)
- Website: adrestia.com
- Phone: +44 01223 804142
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/adrestia-therapeutics-17114 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.